Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Nezahn Tygotaxe
Country: Tajikistan
Language: English (Spanish)
Genre: Life
Published (Last): 17 September 2011
Pages: 41
PDF File Size: 15.66 Mb
ePub File Size: 2.49 Mb
ISBN: 536-3-36016-326-2
Downloads: 63873
Price: Free* [*Free Regsitration Required]
Uploader: Yokinos

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Previous article Next article. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.

Subscribe to our Newsletter. Nine issues are published each year, including mostly originals, reviews and consensus documents. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. They received between 1 to 5 cycles with rTPA.

  DEATHWATCH ERRATA PDF

Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. Continuing navigation will be considered as acceptance of this use.

Are you a health professional able to prescribe or dispense drugs? Print Send to a friend Export reference Mendeley Statistics. There were no deaths or embolism.

SRJ is a prestige metric based on the idea that not all citations are the same. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to recombinantr in life threatening giant thrombus and embolization.

The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. This item has received.

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. Si continua navegando, consideramos que acepta su uso. March Pages ee24 Pages SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

From Monday to Friday from 9 a.

  BIAK NA BATO REPUBLIC PDF

In 4 patients complete resolution of the thrombus was achieved in a mean of 3. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.

Subscriber If you already have your login data, please click here. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.

There was a problem providing the content you requested

You can change the settings or obtain more information by clicking here. Three patients received low molecular weight heparin prior to using rTPA. CiteScore measures average citations received per document published. The patients included 4 males with a mean weight of gr. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical recombinqnte.